{
  "summary": "HS code 3002.51 covers cell cultures, whether or not modified, cell therapy products. It sits in heading 30.02 (human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified) in chapter 30 (pharmaceutical products). Other goods of heading 30.02 are classified under 3002.12 (antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, antisera and other blood fractions), 3002.13 (antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale), 3002.14 (antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, immunological products, mixed, not put up in measured doses or in forms or packings for retail sale), 3002.15 (antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, immunological products, put up in measured doses or in forms or packings for retail sale) or 5 others.",
  "updatedAt": "2026-10-13",
  "facts": [
    {
      "label": "HS code",
      "value": "3002.51",
      "source": "border.bot release GLOBAL:hs #1"
    },
    {
      "label": "Covers",
      "value": "Cell cultures, whether or not modified, cell therapy products",
      "source": "border.bot release GLOBAL:hs #1"
    },
    {
      "label": "Heading",
      "value": "30.02: Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified",
      "source": "border.bot release GLOBAL:hs #1",
      "url": "https://staging.border.bot/hs-codes/3002"
    },
    {
      "label": "Chapter",
      "value": "30: Pharmaceutical products",
      "source": "border.bot release GLOBAL:hs #1",
      "url": "https://staging.border.bot/hs-codes/30"
    },
    {
      "label": "Edition",
      "value": "HS2022",
      "source": "border.bot release GLOBAL:hs #1"
    },
    {
      "label": "Duty rates",
      "value": "Set by each country’s tariff",
      "source": null,
      "url": "https://staging.border.bot/countries"
    }
  ],
  "faq": [
    {
      "question": "What does HS code 3002.51 cover?",
      "answer": "HS code 3002.51 covers cell cultures, whether or not modified, cell therapy products."
    },
    {
      "question": "Which heading and chapter is HS code 3002.51 in?",
      "answer": "HS code 3002.51 is in heading 30.02 (human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified) in chapter 30 (pharmaceutical products)."
    },
    {
      "question": "Where are goods of heading 30.02 classified when 3002.51 doesn’t fit?",
      "answer": "Other goods of heading 30.02 are classified under 3002.12 (antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, antisera and other blood fractions), 3002.13 (antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale), 3002.14 (antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, immunological products, mixed, not put up in measured doses or in forms or packings for retail sale), 3002.15 (antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, immunological products, put up in measured doses or in forms or packings for retail sale) or 5 others."
    }
  ],
  "sections": [
    {
      "id": "covers",
      "title": "What this code covers",
      "text": [
        "HS code 3002.51 covers cell cultures, whether or not modified, cell therapy products.",
        "The legal text of the subheading is “Cell cultures, whether or not modified: Cell therapy products”, read under “Cell cultures, whether or not modified”, in HS2022."
      ]
    },
    {
      "id": "not-covered",
      "title": "What it doesn’t cover",
      "text": [
        "Other goods of heading 30.02 are classified under 3002.12 (antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, antisera and other blood fractions), 3002.13 (antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale), 3002.14 (antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, immunological products, mixed, not put up in measured doses or in forms or packings for retail sale), 3002.15 (antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, immunological products, put up in measured doses or in forms or packings for retail sale) or 5 others."
      ]
    },
    {
      "id": "structure",
      "title": "How it is structured",
      "text": [
        "3002.51 is a six-digit subheading. Its first two digits, 30, are the chapter; the first four, 3002, are heading 30.02; the last two, 51, identify the subheading within the heading.",
        "Countries add their own digits after these six for their national tariff lines."
      ]
    },
    {
      "id": "other-countries",
      "title": "In other countries",
      "text": [
        "No national tariff lines under 3002.51 are live on border.bot yet. Tariffs built on the Harmonized System (HS2022) use 3002.51 at six digits and add their own digits after it."
      ]
    },
    {
      "id": "sources",
      "title": "Sources and updates",
      "text": [
        "The Harmonized System legal text comes from border.bot release 1 (edition HS 2022), imported from a file, and has been live since 13 October 2026.",
        "This page was last updated on 13 October 2026.",
        "Guidance from published tariff data, not a binding ruling. For a decision customs must follow, apply to the destination’s customs authority for a binding tariff ruling."
      ]
    }
  ],
  "data": {
    "type": "hs-subheading",
    "edition": "HS2022",
    "chapter": {
      "code": "30",
      "description": "Pharmaceutical products"
    },
    "heading": {
      "code": "3002",
      "description": "Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified"
    },
    "subheading": {
      "code": "300251",
      "description": "Cell cultures, whether or not modified: Cell therapy products",
      "levels": [
        "Cell cultures, whether or not modified",
        "Cell therapy products"
      ],
      "english": null,
      "keywords": []
    },
    "siblings": [
      {
        "code": "300212",
        "description": "Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes: Antisera and other blood fractions"
      },
      {
        "code": "300213",
        "description": "Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes: Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale"
      },
      {
        "code": "300214",
        "description": "Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes: Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale"
      },
      {
        "code": "300215",
        "description": "Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes: Immunological products, put up in measured doses or in forms or packings for retail sale"
      },
      {
        "code": "300241",
        "description": "Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine"
      },
      {
        "code": "300242",
        "description": "Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for veterinary medicine"
      },
      {
        "code": "300249",
        "description": "Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other"
      },
      {
        "code": "300259",
        "description": "Cell cultures, whether or not modified: Other"
      },
      {
        "code": "300290",
        "description": "Other"
      }
    ],
    "related": [],
    "previous": {
      "code": "300249",
      "description": "Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other",
      "indexable": true
    },
    "next": {
      "code": "300259",
      "description": "Cell cultures, whether or not modified: Other",
      "indexable": true
    },
    "schedules": [],
    "provenance": [
      {
        "dataset": "GLOBAL:hs",
        "country": "GLOBAL",
        "kind": "hs",
        "seq": 1,
        "version": "mytraddal hs2022.csv (HS 2022)",
        "liveAt": "2026-10-13T08:43:06.218Z",
        "origin": "upload",
        "sourceUrls": []
      }
    ],
    "dateModified": "2026-10-13T08:43:06.218Z",
    "seo": {
      "canonicalPath": "/hs-codes/300251",
      "robots": "index",
      "sitemap": true,
      "reasons": [
        "live legal text"
      ]
    }
  },
  "pagination": {
    "page": 1,
    "pages": 1,
    "size": 100,
    "total": 0,
    "prev": null,
    "next": null
  },
  "previous": "https://staging.border.bot/hs-codes/300249",
  "next": "https://staging.border.bot/hs-codes/300259",
  "links": {
    "self": "https://staging.border.bot/hs-codes/300251.json",
    "html": "https://staging.border.bot/hs-codes/300251",
    "canonical": "https://staging.border.bot/hs-codes/300251",
    "markdown": "https://staging.border.bot/hs-codes/300251.md",
    "tools": {
      "calculator": "https://staging.border.bot/tools/landed-cost-calculator",
      "classifier": "https://staging.border.bot/tools/hs-code-classifier",
      "api": "https://staging-api.border.bot/v1"
    }
  },
  "code": "300251",
  "attribution": "border.bot tariff reference (border.bot), compiled from the official publishers named on each page.",
  "terms": "https://staging.border.bot/legal/terms",
  "notice": "Guidance from published tariff data, not a binding ruling. For a decision customs must follow, apply to the destination’s customs authority for a binding tariff ruling.",
  "catalogVersion": "6a955485"
}